<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Clinical trials of M2-based vaccines</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Company (country)</th>
    <th>Phase</th>
    <th>Year</th>
    <th>
     <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">Clinicaltrials.gov</ext-link> identifier
    </th>
    <th>Available results</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>VaxInnate (USA)</td>
    <td>I</td>
    <td>2007–2008</td>
    <td>NCT00603811</td>
    <td>No</td>
   </tr>
   <tr>
    <td>Sanofi (France)</td>
    <td>I</td>
    <td>2007–2009</td>
    <td>NCT00819013</td>
    <td>Yes</td>
   </tr>
   <tr>
    <td>VaxInnate (USA)</td>
    <td>I</td>
    <td>2009</td>
    <td>NCT00921206</td>
    <td>Yes [
     <xref ref-type="bibr" rid="CR123">123</xref>]
    </td>
   </tr>
   <tr>
    <td>VaxInnate (USA)</td>
    <td>II</td>
    <td>2009–2011</td>
    <td>NCT00921947</td>
    <td>Yes</td>
   </tr>
   <tr>
    <td>VaxInnate (USA)</td>
    <td>I/ II</td>
    <td>2009–2010</td>
    <td>NCT00921973</td>
    <td>Yes [
     <xref ref-type="bibr" rid="CR117">117</xref>]
    </td>
   </tr>
   <tr>
    <td>Imutex Limited (United Kingdom)</td>
    <td>I</td>
    <td>2010</td>
    <td>NCT01181336</td>
    <td>No</td>
   </tr>
   <tr>
    <td>GeneOne Life Science (Republic of Korea)</td>
    <td>I</td>
    <td>2010–2012</td>
    <td>NCT01184976</td>
    <td>No</td>
   </tr>
   <tr>
    <td rowspan="2">Theraclone Sciences (USA)</td>
    <td>I</td>
    <td>2012</td>
    <td>NCT01390025</td>
    <td rowspan="2">Yes [
     <xref ref-type="bibr" rid="CR99">99</xref>]
    </td>
   </tr>
   <tr>
    <td>II</td>
    <td>2012</td>
    <td>NCT01719874</td>
   </tr>
   <tr>
    <td>VA Pharma LLC (Russian Federation)</td>
    <td>I</td>
    <td>2018</td>
    <td>NCT03789539</td>
    <td>No</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
